|
|
 |
|
Viewing report
|
|
|
|
Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications
John Wiley and Sons Ltd, Sep 2009, Pages: 1,022
Brings together functional and structural informationrelevant to the design of drugs targeting zinc enzymes
The second most abundant transition element in living organisms, zinc spans all areas of metabolism, with zinc-containing proteins offering both established and potential drug targets. Drug Design of Zinc-Enzyme Inhibitors brings together functional and structural information relevant to these zinc-containing targets. With up-to-date overviews of the latest developments field, this unique and comprehensive text enables readers to understand zinc enzymes and evaluate them in a drug design context.
With contributions from the leaders of today's research, Drug Design of Zinc-Enzyme Inhibitors covers such key topics as:
Major drug targets like carbonic anhydrases, matrix metalloproteinases, bacterial proteases, angiotensin-converting enzyme, histone deacetylase, and APOBEC3G
Roles of recently discovered zinc-containing isozymes in cancer, obesity, epilepsy, pain management, malaria, and other conditions
Cross reactivity of zinc-enzyme inhibitors and activators
The extensive use of X-ray crystallography and QSAR studies for understanding zinc-containing proteins
Clinical applications
An essential resource for the discovery and development of new drug molecules, Drug Design of Zinc-Enzyme Inhibitors gives researchers, professionals, students, and academics the foundation to understand and work with zinc enzyme inhibitors and activators.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Histone Deacetylase inhibitors
Competitor Analysis: Elastase Inhibitors
The Drug Target Atlas of Protein Kinase Inhibitors in Oncology
Competitor Analysis: PARP Inhibitors
Competitor Analysis: Protein Kinase C (PKC) Inhibitors
GPCR - Drug Targets
Competitor Analysis: Heat shock protein 90 (Hsp90) Inhibitors
Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development
Competitor Analysis: PI3K-AKT-mTOR Inhibitors
Structure-Guided Drug Design: Rediscovering the Importance of Drug Structure for Drug Discovery
Competitor Analysis: HDAC Inhibitors
Competitor Analysis: Raf Inhibitors
|
|
|
|
